Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2023/esmo-2023-prostate-cancer/147455-esmo-2023-steap1-x-cd3-xmab-2-1-immune-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-interim-results-phase-1-amg-509-xaluritamig.html
If you do not want to visit that page, you can close this browser tab.
